“No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case-control study and retrospective cohort study.”, Clin Exp Ophthalmol, vol. 47, no. 1, pp. 63-68, 2019.
, “No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.”, Ophthalmology, vol. 126, no. 11, pp. 1541-1548, 2019.
, “No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.”, Ophthalmology, vol. 121, no. 11, pp. 2173-80, 2014.
, “{omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study.”, Am J Clin Nutr, vol. 90, no. 6, pp. 1601-7, 2009.
, “Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration.”, Arch Ophthalmol, vol. 127, no. 1, pp. 110-2, 2009.
, “Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research G”, Ophthalmology, vol. 124, no. 4, pp. 479-487, 2017.
, “Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.”, Ophthalmic Res, vol. 60, no. 1, pp. 38-42, 2018.
, “Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.”, Ophthalmology, vol. 126, no. 12, pp. 1659-1666, 2019.
, “A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3.”, Ophthalmology, vol. 115, no. 4, pp. 599-607.e1, 2008.
, “Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study.”, Ophthalmology, vol. 121, no. 2, pp. 535-44, 2014.
, “Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME Study report number 1.”, Contemp Clin Trials, vol. 37, no. 2, pp. 294-300, 2014.
, “The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.”, Arch Ophthalmol, vol. 125, no. 9, pp. 1225-32, 2007.
, “The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20.”, Arch Ophthalmol, vol. 125, no. 5, pp. 671-9, 2007.
, “The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23.”, Arch Ophthalmol, vol. 126, no. 9, pp. 1274-9, 2008.
, “Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.”, Arch Ophthalmol, vol. 123, no. 9, pp. 1207-14, 2005.
, “Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study.”, Ophthalmology, 2020.
, “Risk assessment model for development of advanced age-related macular degeneration.”, Arch Ophthalmol, vol. 129, no. 12, pp. 1543-50, 2011.
, “Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.”, Ophthalmology, vol. 112, no. 4, pp. 533-9, 2005.
, “Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.”, Ophthalmology, vol. 116, no. 2, pp. 297-303, 2009.
, “The risk of posterior subcapsular cataracts in granulocyte donors.”, Transfusion, vol. 45, no. 11, pp. 1701-8, 2005.
, “Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.”, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-9, 2014.
, “A simplified severity scale for age-related macular degeneration: AREDS Report No. 18.”, Arch Ophthalmol, vol. 123, no. 11, pp. 1570-4, 2005.
, “Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD.”, Invest Ophthalmol Vis Sci, vol. 53, no. 8, pp. 4626-33, 2012.
, “Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.”, JAMA Ophthalmol, vol. 132, no. 3, pp. 272-7, 2014.
, “Ten-year incidence rates of age-related cataract in the Age-Related Eye Disease Study (AREDS): AREDS report no. 33.”, Ophthalmic Epidemiol, vol. 20, no. 2, pp. 71-81, 2013.
,